Vaya Knowledge Hub ยท Safety

Semaglutide side effects: what patients should know

Nausea and other digestive symptoms are well known, but good treatment conversations also cover warning signs, dose changes and what to do when symptoms persist.

Updated 13 Sep 2026Safety guide
Commonly reported effects: nausea, vomiting, diarrhoea, constipation and abdominal discomfort are among the gastrointestinal effects reported with semaglutide. Individual experiences vary, and the product information for the exact medicine should be read carefully.

Why digestive symptoms can occur

GLP-1 medicines affect appetite and gastrointestinal function, including gastric emptying. This is part of why patients may feel full sooner, but it can also contribute to nausea, bloating or changes in bowel habits. Symptoms can vary with dose and between individuals.

Why gradual dose escalation is used

Many semaglutide treatment schedules begin at a lower dose and increase in stages. Patients should follow the schedule for their exact prescribed product rather than copying another person's dose. A clinician may need to review tolerability before changes are made.

When to seek medical advice

Severe or persistent symptoms, significant dehydration, inability to keep fluids down, severe abdominal pain, allergic symptoms or any symptom that feels urgent should be medically assessed. This page cannot determine whether a symptom is serious for a particular person.

Practical questions to discuss

  • What side effects are most common with my exact product?
  • What should I do if nausea interferes with eating or drinking?
  • Which symptoms require urgent assessment?
  • What should I do after a missed dose?
  • How will my dose be reviewed if symptoms are difficult?
  • Could my other medicines be affected by changes in digestion?

Nutrition and hydration

Because appetite can fall, the quality of what a person eats becomes important. Adequate fluids and nutritionally appropriate meals matter. Individual dietary advice should take account of medical conditions, preferences and treatment response.

Do not use this article to self-adjust a prescription. Dosing and treatment changes should follow the instructions for the prescribed medicine and advice from the treating clinician.

FAQs

Does everyone get nausea?

No. Side effects vary substantially between people.

Do side effects mean the medicine is working?

Side effects are not a measure of treatment success. A patient can respond without significant symptoms, and severe symptoms are not something to pursue.

Should I increase the dose if my appetite returns?

Dose changes should follow the prescribed plan and clinical review rather than appetite alone.

References

  1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
  2. Patients should also consult the current prescribing/product information supplied with their exact medicine.

Related guides

Semaglutide in IndiaThe broader patient guide.GLP-1 weight lossHow treatment pathways work.